Search

Your search keyword '"Pavord, I."' showing total 103 results

Search Constraints

Start Over You searched for: Author "Pavord, I." Remove constraint Author: "Pavord, I." Database OpenAIRE Remove constraint Database: OpenAIRE
103 results on '"Pavord, I."'

Search Results

1. Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing

2. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

4. The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD

5. Oral corticosteroid-dependent asthma

6. New understanding in the treatment of cough (NEUROCOUGH) ERS Clinical Research Collaboration: improving care and treatment for patients with cough

7. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

8. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

9. Sputum microbiomic clustering in asthma and COPD reveals a Haemophilus‐predominant subgroup

10. Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey

21. Usability of mepolizumab single-use prefilled autoinjector for patient self-administration

22. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

24. A novel CT scoring system differentiates admissions secondary to eosinophilic from non-eosinophilic asthma

25. Feno and blood eosinophils as biomarkers in predicting asthma exacerbations

26. Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial

27. Lung epithelial cell inhibition of cytokine production by peripheral blood mononuclear cells and lung lymphocytes

28. Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles

29. 'We can't diagnose asthma until <insert arbitrary age>'

30. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

31. Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD

36. Cysteinyl leukotriene E4 activates human ILC2s and enhances the effect of prostaglandin D2 and epithelial cytokines

37. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (vol 6, 29, 2016)

38. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

39. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation

43. Between observer repeatability of sputum differential cell counts. Influence of cell viability and squamous cell contamination

45. The significance of eosinophilic airway inflammation in asthma

48. A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

49. Integrated care pathways for airway diseases (AIRWAYS-ICPs)

50. Fractional exhaled nitric oxide for the management of asthma in adults: Systematic review

Catalog

Books, media, physical & digital resources